Machado, Meyer, Sendacz e Opice Advogados has helped Brazil Pharma in an investment agreement with its subsidiary, pharmaceutical retail chain Big Benn.
Pinheiro
Guimarães - Advogados is advising Big Benn in the deal, which will see Brazil
Pharma acquire a 60 per cent stake for some 293 million reais (US$170 million).
The agreement was signed on 2 February, with closing expected to follow upon
satisfying certain conditions.
Following the purchase, Brazil Pharma will hold an extraordinary shareholders
meeting to approve the acquisition of the remaining 40 per cent of Big Benn
shares to become the full owner of the retail chain. In return, Big Benn’s
sellers will receive 178.6 million reais (US$104 million) worth of ordinary
shares of Brazil Pharma.
Counsel to Brazil Pharma
Machado, Meyer, Sendacz e Opice Advogados
Partner Arthur Penteado and associate Ígor Finzi
Counsel to Big Benn
Pinheiro Guimarães - Advogados
Partners Sergio Ramos Yoshino and Francisco José Pinheiro Guimarães, and
associate Milena Casado de Oliveira
(Latin Lawyer 14.02.2012)
(Notícia na Íntegra)